Clinical Trial Update: Abacavir/Lamivudine Versus Emtricitabine/Tenofovir Both In Combination With Lopinavir/Ritonavir For The Treatment Of HIV [Phase 4]

View source ↗

Summary

Phase 4 trial comparing abacavir/lamivudine versus emtricitabine/tenofovir, each given with lopinavir/ritonavir, in HIV infection to assess efficacy and safety.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Emtricitabine/tenofovir (emtricitabine/tenofovir disoproxil fumarate)
• Lopinavir/ritonavir (lopinavir/ritonavir)
• abacavir/lamivudine (abacavir/lamivudine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: HIV Infection | Phase 4 | Status: COMPLETED | Results posted: 2009-09-15